Mark E Branum

Title: Mark E Branum: Innovator in Immunomodulatory Antibodies

Introduction

Mark E Branum is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of immunology, particularly in the development of antibodies that target specific cells involved in cancer treatment. With a total of 4 patents, his work has the potential to impact therapeutic strategies for cancer patients.

Latest Patents

Among his latest patents are "Immunomodulatory antibodies and methods of use thereof" and "Human CD163 antibodies and uses thereof." These patents describe antibodies that bind to CD163 on cells, such as macrophages. The methods outlined in these patents can be utilized in innovative treatment approaches for cancer, showcasing the importance of his research in the medical field.

Career Highlights

Mark E Branum is currently associated with OncoResponse, Inc., where he continues to advance his research in immunotherapy. His work at this company emphasizes the application of his patented technologies in real-world medical scenarios, aiming to improve patient outcomes.

Collaborations

Throughout his career, Mark has collaborated with esteemed colleagues, including Kamal D Puri and Siddarth Chandrasekaran. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in cancer treatment.

Conclusion

Mark E Branum's contributions to the field of immunology through his patents and work at OncoResponse, Inc. highlight his role as a key innovator in the development of cancer therapies. His ongoing research promises to pave the way for new treatment options that could benefit many patients in the future.